EN | TR
    E-ISSN: 2717-9206
    Bonzai Unusual Effects: A Case Report
    PDF
    Cite
    Share
    Request
    Case Report
    VOLUME: 6 ISSUE: 1
    P: 38-40
    April 2019

    Bonzai Unusual Effects: A Case Report

    J Pediatr Emerg Intensive Care Med 2019;6(1):38-40
    DOI: 10.4274/cayd.galenos.2018.75047
    Halise Akça 1
    Nilden Tuygun 2
    Can Demir Karacan 1
    1. Ankara Yıldırım Beyazıt Üniversitesi Tıp Fakültesi, Çocul Acil Bilim Dalı, Ankara, Türkiye
    2. Dr. Sami Ulus Kadın Doğum, Çocuk Sağlığı ve Hastalıkları Eğitim ve Araştırma Hastanesi, Çocuk Acil Kliniği, Ankara, Türkiye
    No information available.
    No information available
    Received Date: 13.02.2018
    Accepted Date: 30.03.2018
    Publish Date: 21.03.2019
    PDF
    Cite
    Share
    Request

    ABSTRACT

    The use of synthetic cannabinoids is a major health problem in all over the world as well as in our country. These products are synthetic substances created via mixture of cannabinoids and various plants. They are easy to access, inexpensive and undetectable on routine toxicological screening, leading to common use in the adolescent age group. In addition to physical effects, such as nausea, vomiting, sweating, tachycardia, hypertension, chest pain and altered consciousness, psychoactive effects, such as agitation, anxiety, altered perception, hallucinations and panic attacks, are also seen. Here, we present an adolescent patient with bradycardia and acute altered consciousness after bonzai use.

    Keywords: Keywords: Bradycardia, synthetic cannabinoid, poisoning

    References

    1
    Çoban M. The rise of synthetic marijuana in Turkey: the Bonzai phenomenon of the 2010s. Addicta Turk J Addict. 2014:1;41-62.
    2
    Yaşar Durmuş S, Tuygun N, Akça H, Polat E, Karacan CD. Bonzai intoxication in children: our experience with 17 cases. Turk J Pediatr. 2015;57:453-7.
    3
    Besli GE, İkiz MA Yıldırım S, Saltık S. Synthetic cannabinoid abuse in adolescents: A case series. J Emerg Med. 2015;49:644-50.
    4
    Ergül DF, Ekemen S, Yelken BB. Synthetic cannabinoid ‘Bonzai’ intoxication: Six case series. Turk J Anaesth Reanim. 2015;43:347-51.
    5
    Çiftdemir NA, Yücel İ, Duran R, Özbek ÜV, Acunaş B. A new emerging problem in pediatric emergency units: Synthetic cannabinoids. Turk J Pediatr. 2016;58:492-7.
    6
    Efe TH, Felekoğlu MA, Çimen T, Doğan M. Atrial fibrillation following synthetic cannabinoid abuse. Turk Kardiyol Dern Ars. 2017;45:362-4.
    7
    Atik SU, Dedeoğlu R,Varol F, Çam H, Eroğlu AG, et al. Cardiovascular side effects related with use of synthetic cannabinoids “bonzai”: two case reports. Turk Ped Ars. 2015;50:61-4.
    8
    Bhanushali GK, Jain G, Fatima H, Leish LJ, Thornley-Brown D. AKI associated with synthetic cannabinoids: a case series. Clin J Am Soc Nephrol. 2013;8:523-6.
    9
    Aksel G, Güneysel Ö, Taşyürek T, Kozan E, Çevik ŞE. Intravenous lipid emulsion therapy for acute synthetic cannabinoid intoxication: Clinical experience in four cases. Case Rep Emerg Med. 2015;2015:180921.
    10
    Seyit M, Ozen M, Oskay A, Kadioglu E. Effectiveness of the synthetic cannabinoids seminar. Turk J Emerg Med. 2016;16:57-9.
    2024 ©️ Galenos Publishing House